BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 30801863)

  • 1. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
    Haenseler W; Rajendran L
    Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling.
    Muñoz SS; Engel M; Balez R; Do-Ha D; Cabral-da-Silva MC; Hernández D; Berg T; Fifita JA; Grima N; Yang S; Blair IP; Nicholson G; Cook AL; Hewitt AW; Pébay A; Ooi L
    Cells; 2020 Sep; 9(9):. PubMed ID: 32887382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
    Fang M; Liu Y; Huang C; Fan S
    Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.
    Nikel LM; Talbot K; Vahsen BF
    Bioessays; 2024 Jul; 46(7):e2400054. PubMed ID: 38713169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-induced pluripotent stem cells: potential for neurodegenerative diseases.
    Ross CA; Akimov SS
    Hum Mol Genet; 2014 Sep; 23(R1):R17-26. PubMed ID: 24824217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
    Wallings RL; Humble SW; Ward ME; Wade-Martins R
    Trends Neurosci; 2019 Dec; 42(12):899-912. PubMed ID: 31704179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.
    Lall D; Baloh RH
    J Clin Invest; 2017 Sep; 127(9):3250-3258. PubMed ID: 28737506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementia study using induced pluripotent stem cells].
    Matsuzono K; Abe K; Inoue H
    Nihon Rinsho; 2016 Mar; 74(3):443-50. PubMed ID: 27025084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.
    Haenseler W; Sansom SN; Buchrieser J; Newey SE; Moore CS; Nicholls FJ; Chintawar S; Schnell C; Antel JP; Allen ND; Cader MZ; Wade-Martins R; James WS; Cowley SA
    Stem Cell Reports; 2017 Jun; 8(6):1727-1742. PubMed ID: 28591653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rRNA and tRNA Bridges to Neuronal Homeostasis in Health and Disease.
    Tuorto F; Parlato R
    J Mol Biol; 2019 Apr; 431(9):1763-1779. PubMed ID: 30876917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.
    Balez R; Steiner N; Engel M; Muñoz SS; Lum JS; Wu Y; Wang D; Vallotton P; Sachdev P; O'Connor M; Sidhu K; Münch G; Ooi L
    Sci Rep; 2016 Aug; 6():31450. PubMed ID: 27514990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases.
    Li K; Chen Z; Zhang Y; Yang X
    Curr Protein Pept Sci; 2020; 21(12):1202-1217. PubMed ID: 33143625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic manipulation of microglia during brain development and disease.
    Wieghofer P; Prinz M
    Biochim Biophys Acta; 2016 Mar; 1862(3):299-309. PubMed ID: 26432479
    [No Abstract]   [Full Text] [Related]  

  • 18. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
    Noori A; Mezlini AM; Hyman BT; Serrano-Pozo A; Das S
    Neurobiol Dis; 2021 Feb; 149():105225. PubMed ID: 33347974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.